Table of Content

1 Market Overview of Human iPSCs
1.1 Human iPSCs Market Overview
1.1.1 Human iPSCs Product Scope
1.1.2 Human iPSCs Market Status and Outlook
1.2 Global Human iPSCs Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Human iPSCs Market Size by Region (2024-2034)
1.4 Global Human iPSCs Historic Market Size by Region (2024-2024)
1.5 Global Human iPSCs Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Human iPSCs Market Size (2024-2034)
1.6.1 North America Human iPSCs Market Size (2024-2034)
1.6.2 Europe Human iPSCs Market Size (2024-2034)
1.6.3 Asia-Pacific Human iPSCs Market Size (2024-2034)
1.6.4 Latin America Human iPSCs Market Size (2024-2034)
1.6.5 Middle East & Africa Human iPSCs Market Size (2024-2034)
2 Human iPSCs Market by Type
2.1 Introduction
2.1.1 Skin
2.1.2 Blood Cells
2.2 Global Human iPSCs Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Human iPSCs Historic Market Size by Type (2024-2024)
2.2.2 Global Human iPSCs Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Human iPSCs Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Human iPSCs Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Human iPSCs Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Human iPSCs Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Human iPSCs Revenue Breakdown by Type (2024-2034)
3 Human iPSCs Market Overview by Application
3.1 Introduction
3.1.1 Academic Research
3.1.2 Drug Development and Discovery
3.1.3 Toxicity Screening
3.1.4 Regenerative Medicine
3.1.5 Others
3.2 Global Human iPSCs Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Human iPSCs Historic Market Size by Application (2024-2024)
3.2.2 Global Human iPSCs Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Human iPSCs Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Human iPSCs Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Human iPSCs Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Human iPSCs Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Human iPSCs Revenue Breakdown by Application (2024-2034)
4 Human iPSCs Competition Analysis by Players
4.1 Global Human iPSCs Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human iPSCs as of 2022)
4.3 Date of Key Players Enter into Human iPSCs Market
4.4 Global Top Players Human iPSCs Headquarters and Area Served
4.5 Key Players Human iPSCs Product Solution and Service
4.6 Competitive Status
4.6.1 Human iPSCs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Fujifilm Holding Corporation (CDI)
5.1.1 Fujifilm Holding Corporation (CDI) Profile
5.1.2 Fujifilm Holding Corporation (CDI) Main Business
5.1.3 Fujifilm Holding Corporation (CDI) Human iPSCs Products, Services and Solutions
5.1.4 Fujifilm Holding Corporation (CDI) Human iPSCs Revenue (US$ Million) & (2024-2024)
5.1.5 Fujifilm Holding Corporation (CDI) Recent Developments
5.2 Ncardia
5.2.1 Ncardia Profile
5.2.2 Ncardia Main Business
5.2.3 Ncardia Human iPSCs Products, Services and Solutions
5.2.4 Ncardia Human iPSCs Revenue (US$ Million) & (2024-2024)
5.2.5 Ncardia Recent Developments
5.3 Sumitomo Dainippon Pharma
5.3.1 Sumitomo Dainippon Pharma Profile
5.3.2 Sumitomo Dainippon Pharma Main Business
5.3.3 Sumitomo Dainippon Pharma Human iPSCs Products, Services and Solutions
5.3.4 Sumitomo Dainippon Pharma Human iPSCs Revenue (US$ Million) & (2024-2024)
5.3.5 Astellas Pharma Inc Recent Developments
5.4 Astellas Pharma Inc
5.4.1 Astellas Pharma Inc Profile
5.4.2 Astellas Pharma Inc Main Business
5.4.3 Astellas Pharma Inc Human iPSCs Products, Services and Solutions
5.4.4 Astellas Pharma Inc Human iPSCs Revenue (US$ Million) & (2024-2024)
5.4.5 Astellas Pharma Inc Recent Developments
5.5 Fate Therapeutics, Inc
5.5.1 Fate Therapeutics, Inc Profile
5.5.2 Fate Therapeutics, Inc Main Business
5.5.3 Fate Therapeutics, Inc Human iPSCs Products, Services and Solutions
5.5.4 Fate Therapeutics, Inc Human iPSCs Revenue (US$ Million) & (2024-2024)
5.5.5 Fate Therapeutics, Inc Recent Developments
5.6 Pluricell Biotech
5.6.1 Pluricell Biotech Profile
5.6.2 Pluricell Biotech Main Business
5.6.3 Pluricell Biotech Human iPSCs Products, Services and Solutions
5.6.4 Pluricell Biotech Human iPSCs Revenue (US$ Million) & (2024-2024)
5.6.5 Pluricell Biotech Recent Developments
5.7 Cell Inspire Biotechnology
5.7.1 Cell Inspire Biotechnology Profile
5.7.2 Cell Inspire Biotechnology Main Business
5.7.3 Cell Inspire Biotechnology Human iPSCs Products, Services and Solutions
5.7.4 Cell Inspire Biotechnology Human iPSCs Revenue (US$ Million) & (2024-2024)
5.7.5 Cell Inspire Biotechnology Recent Developments
5.8 ReproCELL
5.8.1 ReproCELL Profile
5.8.2 ReproCELL Main Business
5.8.3 ReproCELL Human iPSCs Products, Services and Solutions
5.8.4 ReproCELL Human iPSCs Revenue (US$ Million) & (2024-2024)
5.8.5 ReproCELL Recent Developments
6 North America
6.1 North America Human iPSCs Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Human iPSCs Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Human iPSCs Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Human iPSCs Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Human iPSCs Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Human iPSCs Market Dynamics
11.1 Human iPSCs Industry Trends
11.2 Human iPSCs Market Drivers
11.3 Human iPSCs Market Challenges
11.4 Human iPSCs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Human iPSCs Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Human iPSCs Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Human iPSCs Market Size Share by Region (2024-2024)
Table 4. Global Human iPSCs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Human iPSCs Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Human iPSCs Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Human iPSCs Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Human iPSCs Revenue Market Share by Type (2024-2024)
Table 9. Global Human iPSCs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Human iPSCs Revenue Market Share by Type (2024-2034)
Table 11. North America Human iPSCs Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Human iPSCs Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Human iPSCs Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Human iPSCs Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Human iPSCs Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Human iPSCs Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Human iPSCs Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Human iPSCs Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Human iPSCs Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Human iPSCs Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Human iPSCs Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Human iPSCs Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Human iPSCs Revenue Market Share by Application (2024-2024)
Table 24. Global Human iPSCs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Human iPSCs Revenue Market Share by Application (2024-2034)
Table 26. North America Human iPSCs Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Human iPSCs Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Human iPSCs Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Human iPSCs Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Human iPSCs Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Human iPSCs Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Human iPSCs Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Human iPSCs Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Human iPSCs Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Human iPSCs Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Human iPSCs Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Human iPSCs Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human iPSCs as of 2022)
Table 39. Date of Key Players Enter into Human iPSCs Market
Table 40. Global Human iPSCs Key Players Headquarters and Area Served
Table 41. Human iPSCs Product Solution and Service
Table 42. Global Human iPSCs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Fujifilm Holding Corporation (CDI) Basic Information List
Table 45. Fujifilm Holding Corporation (CDI) Description and Business Overview
Table 46. Fujifilm Holding Corporation (CDI) Human iPSCs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Human iPSCs Business of Fujifilm Holding Corporation (CDI) (2024-2024)
Table 48. Fujifilm Holding Corporation (CDI) Recent Developments
Table 49. Ncardia Basic Information List
Table 50. Ncardia Description and Business Overview
Table 51. Ncardia Human iPSCs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Human iPSCs Business of Ncardia (2024-2024)
Table 53. Ncardia Recent Developments
Table 54. Sumitomo Dainippon Pharma Basic Information List
Table 55. Sumitomo Dainippon Pharma Description and Business Overview
Table 56. Sumitomo Dainippon Pharma Human iPSCs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Human iPSCs Business of Sumitomo Dainippon Pharma (2024-2024)
Table 58. Sumitomo Dainippon Pharma Recent Developments
Table 59. Astellas Pharma Inc Basic Information List
Table 60. Astellas Pharma Inc Description and Business Overview
Table 61. Astellas Pharma Inc Human iPSCs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Human iPSCs Business of Astellas Pharma Inc (2024-2024)
Table 63. Astellas Pharma Inc Recent Developments
Table 64. Fate Therapeutics, Inc Basic Information List
Table 65. Fate Therapeutics, Inc Description and Business Overview
Table 66. Fate Therapeutics, Inc Human iPSCs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Human iPSCs Business of Fate Therapeutics, Inc (2024-2024)
Table 68. Fate Therapeutics, Inc Recent Developments
Table 69. Pluricell Biotech Basic Information List
Table 70. Pluricell Biotech Description and Business Overview
Table 71. Pluricell Biotech Human iPSCs Products, Services and Solutions
Table 72. Revenue (US$ Million) in Human iPSCs Business of Pluricell Biotech (2024-2024)
Table 73. Pluricell Biotech Recent Developments
Table 74. Cell Inspire Biotechnology Basic Information List
Table 75. Cell Inspire Biotechnology Description and Business Overview
Table 76. Cell Inspire Biotechnology Human iPSCs Products, Services and Solutions
Table 77. Revenue (US$ Million) in Human iPSCs Business of Cell Inspire Biotechnology (2024-2024)
Table 78. Cell Inspire Biotechnology Recent Developments
Table 79. ReproCELL Basic Information List
Table 80. ReproCELL Description and Business Overview
Table 81. ReproCELL Human iPSCs Products, Services and Solutions
Table 82. Revenue (US$ Million) in Human iPSCs Business of ReproCELL (2024-2024)
Table 83. ReproCELL Recent Developments
Table 84. North America Human iPSCs Market Size by Country (2024-2024) & (US$ Million)
Table 85. North America Human iPSCs Market Size by Country (2024-2034) & (US$ Million)
Table 86. Europe Human iPSCs Market Size by Country (2024-2024) & (US$ Million)
Table 87. Europe Human iPSCs Market Size by Country (2024-2034) & (US$ Million)
Table 88. Asia-Pacific Human iPSCs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 89. Asia-Pacific Human iPSCs Market Size by Region (2024-2024) & (US$ Million)
Table 90. Asia-Pacific Human iPSCs Market Size by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Human iPSCs Market Share by Region (2024-2024)
Table 92. Asia-Pacific Human iPSCs Market Share by Region (2024-2034)
Table 93. Latin America Human iPSCs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 94. Latin America Human iPSCs Market Size by Country (2024-2024) & (US$ Million)
Table 95. Latin America Human iPSCs Market Size by Country (2024-2034) & (US$ Million)
Table 96. Middle East & Africa Human iPSCs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 97. Middle East & Africa Human iPSCs Market Size by Country (2024-2024) & (US$ Million)
Table 98. Middle East & Africa Human iPSCs Market Size by Country (2024-2034) & (US$ Million)
Table 99. Human iPSCs Market Trends
Table 100. Human iPSCs Market Drivers
Table 101. Human iPSCs Market Challenges
Table 102. Human iPSCs Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human iPSCs Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Human iPSCs Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Human iPSCs Market Share by Regions: 2022 VS 2034
Figure 4. Global Human iPSCs Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Human iPSCs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Human iPSCs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Human iPSCs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Human iPSCs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Human iPSCs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Skin
Figure 11. Global Skin Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Blood Cells
Figure 13. Global Blood Cells Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Human iPSCs Market Size Share by Type: 2022 & 2034
Figure 15. North America Human iPSCs Revenue Market Share by Type (2024-2034)
Figure 16. Europe Human iPSCs Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Human iPSCs Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Human iPSCs Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Human iPSCs Revenue Market Share by Type (2024-2034)
Figure 20. Academic Research Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Drug Development and Discovery Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Toxicity Screening Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Regenerative Medicine Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Human iPSCs Market Size Share by Application: 2022 & 2034
Figure 26. North America Human iPSCs Revenue Market Share by Application (2024-2034)
Figure 27. Europe Human iPSCs Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Human iPSCs Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Human iPSCs Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Human iPSCs Revenue Market Share by Application (2024-2034)
Figure 31. Human iPSCs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Human iPSCs Market Share in 2022
Figure 33. North America Human iPSCs Market Share by Country (2024-2034)
Figure 34. United States Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 37. France Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Human iPSCs Market Share by Region (2024-2034)
Figure 43. China Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 47. India Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Human iPSCs Market Share by Country (2024-2034)
Figure 50. Mexico Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Human iPSCs Market Share by Country (2024-2034)
Figure 53. Turkey Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Human iPSCs Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report